XH6-25391-96921
3 vaccinations
4 coded responses
19 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 941 / CA
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-02-16
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
- 2021-04-03
- 2021-05-18
- 2021-08-17
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Injection site reaction, Rash papular — Feeling: Good · Site: Pain, Redness, SwellingFree text: Raised bump at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Injection site mass — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body aches, Fatigue or tirednessFree text: Two lumps at and adjacent to injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Injection site mass — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessFree text: One bump still at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-30
- 2022-03-30
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: Chills, Dyspnoea, Malaise, Myalgia, Pregnancy, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: 2 weeks ago had COVID-like symptoms - shortness of breath, extreme muscle aches and chills. Subsequently had 4 negative home tests, and 1 negative PCR test. I am also 21 weeks pregnant.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-30
-
2022-09-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-29 | Successful 2022-09-30 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Raised bump at injection site
Systemic reaction (other): Two lumps at and adjacent to injection site
Systemic reaction (other): One bump still at injection site
Release 12 — 12 months, dose 3
Symptoms: 2 weeks ago had COVID-like symptoms - shortness of breath, extreme muscle aches and chills. Subsequently had 4 negative home tests, and 1 negative PCR test. I am also 21 weeks pregnant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Injection site mass | · | · | ✓ |
| SRO | Injection site reaction | · | · | ✓ |
| SRO | Rash papular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release